Kaplan-Meier survival curves of tiotropium and non-tiotropium groups among patient without airflow limitation. (a) before propensity score matching; (b) after propensity score matching. (TIFF 101 kb
Figure S2. This figure shows a Kaplan-Meier curve for hospital survival of immunocompromised patient...
Table S1. Inclusion and exclusion criteria of the named patient use programme for nintedanib. IPF, i...
Treatment duration in days of MDR-TB patients who have completed treatment, a table showing the trea...
Probability distribution of tiotropium and non-tiotropium groups. (a) before propensity score matchi...
Baseline characteristics of patients in tiotropium and non-tiotropium groups among patients with air...
Baseline characteristics of patients in tiotropium and non-tiotropium groups among patients without ...
Baseline characteristics of patients in tiotropium and non-tiotropium groups among patients without ...
Forest plot of risk factors for mortality in patients with tuberculous destroyed lung (results from ...
Forest plot of annual rate of FVC (A) and FEV1/FVC (B) decline in lung function by baseline characte...
Including study details for all publications included in this review. (DOCX 48 kb
Pearsonâs correlation coefficients: night-time awakening scores and 36-item Short-Form Health Surv...
Figure S2. 30-day all-cause mortality (ITT population). a. 30-day all-cause mortality in patients wi...
KaplanâMeier plots of cumulative transplant-free survival in patients with pulmonary arterial hype...
Figure S1. Kaplan-Meier curve for hospital survival in immunocompromised patients according to ARDS ...
Table S4. Baseline characteristics of the study sample within Sensitivity Analysis 2. (DOC 56 kb
Figure S2. This figure shows a Kaplan-Meier curve for hospital survival of immunocompromised patient...
Table S1. Inclusion and exclusion criteria of the named patient use programme for nintedanib. IPF, i...
Treatment duration in days of MDR-TB patients who have completed treatment, a table showing the trea...
Probability distribution of tiotropium and non-tiotropium groups. (a) before propensity score matchi...
Baseline characteristics of patients in tiotropium and non-tiotropium groups among patients with air...
Baseline characteristics of patients in tiotropium and non-tiotropium groups among patients without ...
Baseline characteristics of patients in tiotropium and non-tiotropium groups among patients without ...
Forest plot of risk factors for mortality in patients with tuberculous destroyed lung (results from ...
Forest plot of annual rate of FVC (A) and FEV1/FVC (B) decline in lung function by baseline characte...
Including study details for all publications included in this review. (DOCX 48 kb
Pearsonâs correlation coefficients: night-time awakening scores and 36-item Short-Form Health Surv...
Figure S2. 30-day all-cause mortality (ITT population). a. 30-day all-cause mortality in patients wi...
KaplanâMeier plots of cumulative transplant-free survival in patients with pulmonary arterial hype...
Figure S1. Kaplan-Meier curve for hospital survival in immunocompromised patients according to ARDS ...
Table S4. Baseline characteristics of the study sample within Sensitivity Analysis 2. (DOC 56 kb
Figure S2. This figure shows a Kaplan-Meier curve for hospital survival of immunocompromised patient...
Table S1. Inclusion and exclusion criteria of the named patient use programme for nintedanib. IPF, i...
Treatment duration in days of MDR-TB patients who have completed treatment, a table showing the trea...